You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Based on empirical research from over 240 interviews, the authors present new concepts and trends in global R&D management. Case studies from 18 best-practice companies give detailed answers to the most pressing challenges for mastering international innovation.
"The Oxford Handbook of China Innovation provides a contemporary and authoritative view of the role of innovation in China's extraordinary emergence. The Handbook consists of chapters written by over sixty experts from universities and research institutions worldwide, who describe and analyze this phenomenon with criticism, discussion of policy issues, and views about further development. It focuses on the microeconomic factors in China's growth, of which the critical force has been the steady drive for innovation. It identifies the many factors instrumental in the development of innovation and evaluates those that are specific to China's context, and those applicable to other nations. The s...
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies. The authors focus on three sources of pharmaceutical innovation: new management methods, new technologies, and new forms of internationalization. Their findings are illustrated in the case of the Swiss pharmaceutical industry, the leading exporter of pharmaceutical products in percentage of GDP, and some of its main pharmaceutical firms such as Novartis and Hoffmann-La Roche.
Pharmaceutical giants have been doubling their investments in drug development, only to see new drug approvals to remain constant for the past decade. This book investigates and highlights a set of proactive strategies, aimed at generating sustainable competitive advantage for its protagonists based on value-generating business practices. We focus on three sources of pharmaceutical innovation: new management methods in the drug development pipeline, new technologies as enablers for cutting-edge R&D, and new forms of internationalisation, such as outside-in innovation in the early phases of R&D.
This book analyses the relationships among product safety strategy and culture, concurrent engineering, new product development (NPD) processes and product safety performance. Product safety is a matter of enormous economic and societal concern, given the safety risks to consumers and the financial risks to producers. Nevertheless, a thorough conceptual understanding of the effects of NPD policies and practices is still largely missing, as several large-scale trends have made clarifying the role of product safety in its socio-economic context difficult, including: the rise of consumerism and the shift in the balance of power from manufacturers to customers and regulators; the internationaliz...
Reveals the breadth of innovation in emerging markets, from drivers and types to outcomes and implications.
This new book is the first full account, inside or outside government, of China’s efforts to acquire foreign technology. Based on primary sources and meticulously researched, the book lays bare China’s efforts to prosper technologically through others' achievements. For decades, China has operated an elaborate system to spot foreign technologies, acquire them by all conceivable means, and convert them into weapons and competitive goods—without compensating the owners. The director of the US National Security Agency recently called it "the greatest transfer of wealth in history." Written by two of America's leading government analysts and an expert on Chinese cyber networks, this book d...
"Undisputedly, China has become the world's manufacturing powerhouse, accounting for more than two-thirds of the world's output in DVD players, children's toys, and microwave ovens, as well as half of all personal computers, digital cameras and kitchen appliances. However, China is not only a low-cost manufacturing country, it is also in the process of transitioning towards becoming a major source of global innovation, by creating pioneering new business models and policy frameworks alongside the technical inventions the country has become known for. This book documents China's transition by highlighting the key elements, events, underlying trends and drivers that have contributed towards Ch...
The volume focuses on the issue of globalization of research and development (R&D) in China. China has become the number one choice of R&D for multination corporations (MNCs), according to a recent survey. Many of the largest MNCs in the world, such as Microsoft, GE, GM, HP, Motorola, and Lucent, among hundred of others, have established R&D facilities. The phenomenon has become a hot issue among policy debates in many countries regarding job outsourcing, national and regional competitiveness, and China. This book examines the issue of foreign R&D, particularly, those from MNCs in China: the drivers, missions, locations, management challenges, policies, and implications for China’s innovation system. This book was previously published as a special issue of the Asian Pacific Business Review.